Skip to main content

Table 1 Overview of study design in five studies evaluating the efficacy of treatment with moxidectin against the JYD-34 isolate of Dirofilaria immitis

From: Efficacy of moxidectin, using various dose regimens, against JYD-34, a macrocyclic lactone resistant isolate of Dirofilaria immitis

Study no.1

Calendar year of execution

Group

No. of dogs per group

Treatment2

Dose (µg/kg)

Day(s) of treatment3

Days post infection of necropsy

No. of dogs with worms

Worm count range

Worm count geometric mean

% Efficacy

P-value4

1

2013

A

4

Control

N/A5

N/A

148

4

30–37

32.9

N/A

N/A

B

4

Moxidectin

30

0, 30, 60

148

2

0–3

0.7

97.9

0.0030

C

4

Moxidectin

50

0, 30, 60

148

1

0–2

0.3

99.0

0.0009

D

4

Moxidectin

100

0

148

4

1–9

2.9

91.1

0.0133

2

2017

A

5

Control

N/A

N/A

180

5

8–29

15.2

N/A

N/A

B

4

Moxidectin

9

0, 30, 60, 90, 120

180

1

0–1

0.2

98.8

 < 0.0001

3

2017

A

5

Control

N/A

N/A

176

5

32–39

34.5

N/A

N/A

B

4

Moxidectin

9

0, 31, 61, 90, 119

176

4

1–6

2.0

94.1

0.0025

4

2017

A

5

Control

N/A

N/A

181

5

23–51

35.9

N/A

N/A

B

4

Moxidectin

6

0, 31, 60, 90, 119

181

4

1–14

6.0

83.3

0.0277

5

2018

A

5

Control

N/A

N/A

180

5

29–48

38.0

N/A

N/A

B

4

Moxidectin

6

0, 31, 60, 90, 1196

180

4

1–6

3.7

90.2

0.0021

  1. 1No. = Number
  2. 2Control dogs were not treated
  3. 3All dogs were inoculated on Day −30 for each study
  4. 4P-value = Two-sided probability value from analysis of variance on log counts of moxidectin and control at α = 0.05
  5. 5N/A = not applicable
  6. 6One dog in the treated group did not have measurable levels of moxidectin following the Day 119 dose